Results 231 to 240 of about 185,125 (388)
Reply — on gastric polyps, proton pump inhibitors and long‐term risks [PDF]
Helge L. Waldum, Eiliv Brenna
openalex +1 more source
Endoscopic suturing ligation and fundoplication for proton pump inhibitor-resistant severe reflux esophagitis. [PDF]
Mori H+5 more
europepmc +1 more source
Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley +1 more source
Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors [PDF]
S. Xue+4 more
openalex +1 more source
The Duration of Proton Pump Inhibitor Therapy and the Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis. [PDF]
Khurmatullina AR+6 more
europepmc +1 more source
Abstract The industrial production of citric acid, an ingredient in beverages, pharmaceuticals, and cosmetics, is based on microbial fermentation of glucose or sucrose. Given the elevated cost of these sugars, lignocellulosic biomass is emerging as a cost‐effective and environmentally friendly feedstock for sustainable bioprocesses.
Ludovica Varriale+4 more
wiley +1 more source
Fundic Gland Polyps Are Not Induced by Proton Pump Inhibitor Therapy [PDF]
Michael Vieth, Manfred Stolte
openalex +1 more source
Visibility Evaluation of Fundic Gland Polyp Associated With Proton Pump Inhibitor in Texture and Color Enhancement Imaging. [PDF]
Uchida R+17 more
europepmc +1 more source